Asset Advisors Investment Management, LLC Amgen Inc Transaction History

Asset Advisors Investment Management, LLC

  • $1.1 Billion
  • Q4 2025

A detailed history of Asset Advisors Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Asset Advisors Investment Management, LLC holds 35,514 shares of AMGN stock, worth $12.1 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
35,514
Previous 35,134 1.08%
Holding current value
$12.1 Million
Previous $9.91 Million 22.4%
% of portfolio
1.1%
Previous 0.95%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026
BUY
$290.13 - $341.71 $110,249 - $129,849
380 Added 1.08%
35,514 $12.1 Million
Q3 2025

Oct 23, 2025
BUY
$271.18 - $309.22 $148,335 - $169,143
547 Added 1.58%
35,134 $9.91 Million
Q2 2025

Jul 21, 2025
SELL
$262.28 - $309.85 $3,671 - $4,337
-14 Reduced 0.04%
34,587 $9.66 Million
Q1 2025

May 02, 2025
SELL
$258.59 - $327.36 $133,432 - $168,917
-516 Reduced 1.47%
34,601 $10.8 Million
Q4 2024

Feb 04, 2025
SELL
$258.78 - $328.31 $211,423 - $268,229
-817 Reduced 2.27%
35,117 $9.15 Million
Q3 2024

Nov 26, 2024
BUY
$309.38 - $337.38 $913,908 - $996,620
2,954 Added 8.96%
35,934 $11.6 Million
Q2 2024

Aug 14, 2024
BUY
$262.75 - $319.31 $217,819 - $264,707
829 Added 2.58%
32,980 $10.3 Million
Q1 2024

May 14, 2024
BUY
$268.87 - $324.56 $104,859 - $126,578
390 Added 1.23%
32,151 $9.14 Million
Q4 2023

Feb 02, 2024
BUY
$255.7 - $288.46 $212,998 - $240,287
833 Added 2.69%
31,761 $9.15 Million
Q3 2023

Oct 26, 2023
SELL
$218.65 - $271.46 $38,919 - $48,319
-178 Reduced 0.57%
30,928 $8.31 Million
Q2 2023

Aug 03, 2023
SELL
$214.27 - $253.37 $332,118 - $392,723
-1,550 Reduced 4.75%
31,106 $6.91 Million
Q1 2023

Apr 25, 2023
SELL
$225.79 - $275.2 $597,666 - $728,454
-2,647 Reduced 7.5%
32,656 $7.89 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $351,561 - $446,700
1,535 Added 4.55%
35,303 $9.27 Million
Q3 2022

Nov 01, 2022
BUY
$224.46 - $253.15 $501,668 - $565,790
2,235 Added 7.09%
33,768 $7.61 Million
Q2 2022

Jul 28, 2022
BUY
$230.71 - $256.74 $193,796 - $215,661
840 Added 2.74%
31,533 $7.67 Million
Q1 2022

Apr 22, 2022
BUY
$219.27 - $242.57 $3.31 Million - $3.67 Million
15,111 Added 96.98%
30,693 $7.42 Million
Q4 2021

Jan 27, 2022
BUY
$198.88 - $227.6 $41,764 - $47,796
210 Added 1.37%
15,582 $3.51 Million
Q3 2021

Oct 29, 2021
SELL
$212.27 - $248.7 $4.2 Million - $4.93 Million
-19,804 Reduced 56.3%
15,372 $3.27 Million
Q2 2021

Jul 16, 2021
BUY
$233.58 - $259.14 $53,022 - $58,824
227 Added 0.65%
35,176 $8.57 Million
Q1 2021

Apr 15, 2021
BUY
$221.91 - $258.6 $609,142 - $709,857
2,745 Added 8.52%
34,949 $8.7 Million
Q4 2020

Jan 21, 2021
BUY
$216.38 - $257.67 $236,503 - $281,633
1,093 Added 3.51%
32,204 $7.4 Million
Q3 2020

Oct 20, 2020
SELL
$234.65 - $260.95 $226,437 - $251,816
-965 Reduced 3.01%
31,111 $7.91 Million
Q2 2020

Jul 21, 2020
SELL
$197.81 - $242.74 $275,153 - $337,651
-1,391 Reduced 4.16%
32,076 $7.57 Million
Q1 2020

Apr 23, 2020
BUY
$182.24 - $241.7 $3,644 - $4,834
20 Added 0.06%
33,467 $6.79 Million
Q4 2019

Jan 22, 2020
BUY
$189.21 - $243.2 $69,061 - $88,768
365 Added 1.1%
33,447 $8.03 Million
Q3 2019

Oct 23, 2019
BUY
$174.11 - $208.62 $974,145 - $1.17 Million
5,595 Added 20.36%
33,082 $6.4 Million
Q2 2019

Jul 25, 2019
BUY
$166.7 - $195.41 $215,876 - $253,055
1,295 Added 4.94%
27,487 $5.07 Million
Q1 2019

Apr 16, 2019
BUY
$180.87 - $203.88 $29,120 - $32,824
161 Added 0.62%
26,192 $4.98 Million
Q4 2018

Jan 28, 2019
SELL
$178.4 - $208.25 $289,008 - $337,365
-1,620 Reduced 5.86%
26,031 $5.07 Million
Q3 2018

Oct 26, 2018
BUY
$185.29 - $208.89 $5.12 Million - $5.78 Million
27,651 New
27,651 $5.73 Million

Others Institutions Holding AMGN

# of Institutions
3,319
Shares Held
428M
Call Options Held
6.11M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Asset Advisors Investment Management, LLC Portfolio

Follow Asset Advisors Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Advisors Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Advisors Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email